US$ 23.00
saxenda glp-1 diabetes market impact New Demand in an Old GLP-1 Analogues Market Size, Share,
Description
2026: Acceleration and Market Transformation The coming year promises rapid evolution across innovation, policy, and market access

Wegovy es uno de los nombres comerciales de la semaglutida, el frmaco ms conocido como Ozempic

By Shipra Patel, M.D.

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, including a reduced risk of blindness

Designed for adults wanting plant-based support for healthy eating habits

Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 drugs
